[1] HUANG JL.Clinical efficacy of Jianpi Bushen prescription combined with ursodeoxycholic acid in treatment of primary biliary cirrhosis[D].Shanghai:Shanghai Univ Tradit Chin Med,2011.(in Chinese)黄君兰.健脾补肾方联合熊去氧胆酸治疗原发性胆汁性肝硬化的临床观察[D].上海:上海中医药大学,2011.
|
[2]HAN XH,CHEN JM,ZHANG L,et al.Effects of Qinggan Huoxue formula on gene expression during endoplasmic reticulum stress-induced apoptosis in rats with ethanol-induced liver injury[J].World Chin J Dig,2009,17(13):1279-1285.(in Chinese)韩向晖,陈珺明,张莉,等.清肝活血方对酒精性肝损伤大鼠内质网应激反应性凋亡基因表达的影响[J].世界华人消化杂志,2009,17(13):1279-1285.
|
[3]HAN XH,WANG JY,ZHENG PY,et al.Attenuation and mechanism of endoplasmic reticulum stress-mediated hepatocyte apoptosis in rats with alcohol-induced liver injury by qinggan huoxue recipe and its disassembled formulas[J].Chin J Integr Tradit West Med,2011,31(5):653-658.(in Chinese)韩向晖,王见义,郑培永,等.清肝活血方及其拆方抗酒精性肝损伤大鼠肝细胞内质网应激性凋亡的作用及机制[J].中国中西医结合杂志,2011,31(5):653-658.
|
[4]WANG L,DU H,LIU Y,et al.Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis[J].Evid Based Complement Alternat Med,2015,2015:461294.
|
[5] ZHAO W.Comparison of anti-hepatic fibrosis effects of blood-activating and stasis-resolving analogous prescriptions and their mechanisms of action against lipid peroxidation damage[D].Shanghai:Shanghai Univ Tradit Chin Med,2012.(in Chinese)赵韦.活血化瘀类方抗肝纤维化疗效比较及其抗脂质过氧化损伤的作用机制[D].上海:上海中医药大学,2012.
|
[6]DONG ZH,XU HY,QI HB.Clinical observation of integrative Chinese and Western medicine in treatment of 25 cases of primary biliary cirrhosis[J].World J Integr Tradit Western Med,2009,4(3):185-188.(in Chinese)董振华,徐慧媛,齐贺彬.中西医结合治疗原发性胆汁性肝硬化25例临床观察[J].世界中西医结合杂志,2009,4(3):185-188.
|
[7]ZHAO SG,CHEN X,LEI KJ,et al.Effects of spleen-strengthening,kidney-tonifying,and liver-soothing therapy on lipid peroxidation and cytokines in patients with nonalcoholic fatty liver disease[J].Chin J Integr Tradit West Med Liver Dis,2013,23(5):301-302.(in Chinese)赵书刚,陈昕,雷开键,等.健脾补肾疏肝法对非酒精性脂肪性肝病患者脂质过氧化和细胞因子的影响[J].中西医结合肝病杂志,2013,23(5):301-302.
|
[8]YU H,BAO YJ,HU SJ,et al.The effects of jianpi bushen fang on the expression of VEGF in the of BALB/c mouse model of colorectal liver metastases[J].J Liaoning Univ Tradit Chin Med,2015,17(4):151-153.(in Chinese)于卉,包益洁,胡送娇,等.健脾补肾方对BALB/c鼠大肠癌肝转移模型中VEGF表达的影响[J].辽宁中医药大学学报,2015,17(4):151-153.
|
[9]ZHOU ZH,SUN XH,LI M,et al.Effect of kidney-tonifying and spleen-strengthening prescription on PD-1 and PD-L1 expression in HBeA g-positive chronic hepatitis B patients with slightly increased ALT levels[J].J Clin Hepatol,2015,31(1):58-62.(in Chinese)周振华,孙学华,李曼,等.补肾健脾方对ALT轻度升高的HBeA g阳性慢性乙型肝炎患者程序性死亡受体1/程序性死亡配体1表达的影响[J].临床肝胆病杂志,2015,31(1):58-62.
|
[10]ZHAO J.Clinical efficacy of regulating and supplementing liverspleen and kidney formula combiend with Western medicine for treatment of cirrhosis[J].Liaoning J Tradit Chin Med,2014,41(5):977-979.(in Chinese)赵娟.调肝健脾补肾方联合西医治疗肝硬化腹水临床观察[J].辽宁中医杂志,2014,41(5):977-979.
|
[11]ZHANG XL,LU LW,TANG SX,et al.“Combined equally important treatment and nursing”in prevention and treatment of HBV[J].Jilin J Tradit Chin Med,2016,36(7):656-658.(in Chinese)张向磊,卢立伟,唐世霞,等.治养并重、养治结合防治乙型病毒性肝炎[J].吉林中医药,2016,36(7):656-658.
|
[12]CHEN Y,FANG J,CHEN X,et al.Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Med,2015,9(2):573-578.
|
[13]YANG CY,MA X,TSUNEYAMA K,et al.IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis:implications for therapy[J].Hepatology,2014,59(5):1944-1953.
|
[14]ZHOU L,IVANOV II,SPOLSKI R,et al.IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways[J].Nat Immunol,2007,8(9):967-974.
|
[15]RONG G,ZHOU Y,XIONG Y,et al.Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis:the serum cytokine profile and peripheral cell population[J].Clin Exp Immunol,2009,156(2):217-225.
|